Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 16:14:1328419.
doi: 10.3389/fcimb.2024.1328419. eCollection 2024.

Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis

Affiliations
Review

Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis

Fan Tang et al. Front Cell Infect Microbiol. .

Abstract

Endometriosis (EMs) is a prevalent gynecological disorder characterized by the growth of uterine tissue outside the uterine cavity, causing debilitating symptoms and infertility. Despite its prevalence, the exact mechanisms behind EMs development remain incompletely understood. This article presents a comprehensive overview of the relationship between gut microbiota imbalance and EMs pathogenesis. Recent research indicates that gut microbiota plays a pivotal role in various aspects of EMs, including immune regulation, generation of inflammatory factors, angiopoietin release, hormonal regulation, and endotoxin production. Dysbiosis of gut microbiota can disrupt immune responses, leading to inflammation and impaired immune clearance of endometrial fragments, resulting in the development of endometriotic lesions. The dysregulated microbiota can contribute to the release of lipopolysaccharide (LPS), triggering chronic inflammation and promoting ectopic endometrial adhesion, invasion, and angiogenesis. Furthermore, gut microbiota involvement in estrogen metabolism affects estrogen levels, which are directly related to EMs development. The review also highlights the potential of gut microbiota as a diagnostic tool and therapeutic target for EMs. Interventions such as fecal microbiota transplantation (FMT) and the use of gut microbiota preparations have demonstrated promising effects in reducing EMs symptoms. Despite the progress made, further research is needed to unravel the intricate interactions between gut microbiota and EMs, paving the way for more effective prevention and treatment strategies for this challenging condition.

Keywords: endometriosis; gut microbiota; immune; inflammatory; lipopolysaccharide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The influence of gut microbiota on the pathogenesis of endometriosis. Metabolites and endotoxins produced by the intestinal microbiota can lead to weakened intestinal barrier function and increased intestinal mucosal permeability. Multiple aspects such as immune system regulation, release of inflammatory factors, angiogenesis-related substances involvement, hormonal regulation, and endotoxin production are comprehensively involved in creating a favorable environment for the occurrence and development of endometriosis.

Similar articles

Cited by

References

    1. Ahn S. H., Edwards A. K., Singh S. S., Young S. L., Lessey B. A., Tayade C. (2015. a). IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors. J. Immunol. 195, 2591–2600. doi: 10.4049/jimmunol.1501138 - DOI - PMC - PubMed
    1. Ahn S. H., Monsanto S. P., Miller C., Singh S. S., Thomas R., Tayade C. (2015. b). Pathophysiology and immune dysfunction in endometriosis. BioMed. Res. Int. 2015, 795976. doi: 10.1155/2015/795976 - DOI - PMC - PubMed
    1. Al-Asmakh M., Zadjali F. (2015). Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583–1588. doi: 10.4014/jmb.1501.01039 - DOI - PubMed
    1. Allaire J. M., Crowley S. M., Law H. T., Chang S.-Y., Ko H.-J., Vallance B. A. (2018). The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol. 39, 677–696. doi: 10.1016/j.it.2018.04.002 - DOI - PubMed
    1. Allaire C., Bedaiwy M. A., Yong P. J. (2023). Diagnosis and management of endometriosis. CMAJ 195 (10), E363–E371. doi: 10.1503/cmaj.220637 - DOI - PMC - PubMed